Research and Development

The Research and Development team at Engitix Therapeutics leverages the company's pioneering human extracellular matrix (ECM)-based discovery platform to create innovative therapeutic programs targeting fibrosis and solid tumors. Comprising experts in biospecimens, biology, biomaterials, fibrosis, medicinal chemistry, and immuno-oncology, the team focuses on advancing the understanding and treatment of life-threatening diseases to ensure a healthier future for patients.